Alnylam Pharmaceuticals Valuation

ALNY Stock  USD 149.45  4.94  3.20%   
At this time, the firm appears to be overvalued. Alnylam Pharmaceuticals shows a prevailing Real Value of $112.09 per share. The current price of the firm is $149.45. Our model approximates the value of Alnylam Pharmaceuticals from analyzing the firm fundamentals such as Current Valuation of 18.3 B, profit margin of (0.24) %, and Return On Equity of -15.01 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Price Book
142.9249
Enterprise Value
18.3 B
Enterprise Value Ebitda
(85.03)
Price Sales
10.4857
Enterprise Value Revenue
10.0111
Overvalued
Today
149.45
Please note that Alnylam Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Alnylam Pharmaceuticals is based on 3 months time horizon. Increasing Alnylam Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Alnylam Pharmaceuticals is useful when determining the fair value of the Alnylam stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Alnylam Pharmaceuticals. Since Alnylam Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Alnylam Stock. However, Alnylam Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  149.45 Real  112.09 Target  229.39 Hype  149.45 Naive  152.8
The real value of Alnylam Stock, also known as its intrinsic value, is the underlying worth of Alnylam Pharmaceuticals Company, which is reflected in its stock price. It is based on Alnylam Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Alnylam Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Alnylam Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
109.84
Downside
112.09
Real Value
164.40
Upside
Estimating the potential upside or downside of Alnylam Pharmaceuticals helps investors to forecast how Alnylam stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Alnylam Pharmaceuticals more accurately as focusing exclusively on Alnylam Pharmaceuticals' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-1.56-1.18-0.27
Details
Hype
Prediction
LowEstimatedHigh
147.20149.45151.70
Details
Naive
Forecast
LowNext ValueHigh
150.55152.80155.06
Details
28 Analysts
Consensus
LowTarget PriceHigh
208.74229.39254.62
Details

Alnylam Pharmaceuticals Investments

(223.82 Million)

Alnylam Pharmaceuticals Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Alnylam Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Alnylam Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alnylam Pharmaceuticals competition to find correlations between indicators driving Alnylam Pharmaceuticals's intrinsic value. More Info.
Alnylam Pharmaceuticals is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies . Price To Book Ratio is likely to rise to -102.94 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Alnylam Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Alnylam Pharmaceuticals' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alnylam Pharmaceuticals' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Alnylam Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Alnylam Pharmaceuticals and how it compares across the competition.

About Alnylam Pharmaceuticals Valuation

The stock valuation mechanism determines the current worth of Alnylam Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Alnylam Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Alnylam Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Alnylam Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Alnylam Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alnylam Pharmaceuticals. We calculate exposure to Alnylam Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Alnylam Pharmaceuticals's related companies.
Last ReportedProjected for 2024
Gross Profit1.5 B1.6 B
Pretax Profit Margin(0.24)(0.25)
Operating Profit Margin(0.15)(0.16)
Net Loss(0.24)(0.25)
Gross Profit Margin 0.83  0.96 

8 Steps to conduct Alnylam Pharmaceuticals' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Alnylam Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Alnylam Pharmaceuticals' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Alnylam Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Alnylam Pharmaceuticals' revenue streams: Identify Alnylam Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Alnylam Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Alnylam Pharmaceuticals' growth potential: Evaluate Alnylam Pharmaceuticals' management, business model, and growth potential.
  • Determine Alnylam Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Alnylam Pharmaceuticals' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Alnylam Pharmaceuticals Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Alnylam Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding124.9 M

Alnylam Pharmaceuticals Current Valuation Indicators

Valuation refers to the process of determining the present value of Alnylam Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Alnylam we look at many different elements of the entity such as Alnylam's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Alnylam Pharmaceuticals' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Alnylam Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Alnylam Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Alnylam Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Alnylam Pharmaceuticals' worth.
When determining whether Alnylam Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alnylam Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alnylam Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alnylam Pharmaceuticals Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alnylam Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Alnylam Stock please use our How to Invest in Alnylam Pharmaceuticals guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Alnylam Stock analysis

When running Alnylam Pharmaceuticals' price analysis, check to measure Alnylam Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alnylam Pharmaceuticals is operating at the current time. Most of Alnylam Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alnylam Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alnylam Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alnylam Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Transaction History
View history of all your transactions and understand their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Alnylam Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alnylam Pharmaceuticals. If investors know Alnylam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alnylam Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.52)
Revenue Per Share
14.637
Quarterly Revenue Growth
0.312
Return On Assets
(0.05)
Return On Equity
(15.01)
The market value of Alnylam Pharmaceuticals is measured differently than its book value, which is the value of Alnylam that is recorded on the company's balance sheet. Investors also form their own opinion of Alnylam Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Alnylam Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alnylam Pharmaceuticals' market value can be influenced by many factors that don't directly affect Alnylam Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alnylam Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alnylam Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alnylam Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.